Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,406,089
- Total 13F shares
- 236,653,399
- Share change
- +491,126
- Total reported value
- $114,743,267,144
- Put/Call ratio
- 77%
- Price per share
- $484.82
- Number of holders
- 1,597
- Value change
- +$569,969,794
- Number of buys
- 820
- Number of sells
- 693
Report period
Q1 2025
Institutions
1,597
Top holders
10
VRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Ownership snapshot
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
FMR LLC
Evidence rows
50
Latest as of
31 Dec 2024
13D/G
13F
Lead comparable stake: 3.6%
13D/G row: FMR LLC
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
3.6%
|
$4,642,686,284
9,220,827 shares
|
$0 | 31 Dec 2024 |
| Capital World Investors |
13F
Company
|
11%
|
$11,406,666,988
28,325,695 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.1%
|
$9,366,112,578
23,258,288 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
8.6%
|
$8,789,116,493
21,825,470 shares
|
— | 31 Dec 2024 |
| STATE STREET CORP |
13F
Company
|
4.7%
|
$4,823,868,882
11,979,405 shares
|
— | 31 Dec 2024 |
| Capital Research Global Investors |
13F
Company
|
4.1%
|
$4,199,713,394
10,428,951 shares
|
— | 31 Dec 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.5%
|
$2,542,288,504
6,313,107 shares
|
— | 31 Dec 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.3%
|
$2,382,407,028
5,916,084 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,597
Shares
236,653,399
Rows loaded
1,607
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
1,542
Q1 2025 holders
1,597
Holder diff
55
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend